Hydrocodone Bitartrate/Homatropine Methylbromide Syrup CII
Generic Name and Formulations:
Hydrocodone bitartrate 5mg, homatropine methylbromide 1.5mg; per 5mL.
Various generic manufacturers
Indications for Hydrocodone Bitartrate/Homatropine Methylbromide Syrup:
Use accurate measuring device. ≥12yrs: 5mL every 4–6hrs as needed; max 30mL/24hrs.
Use accurate measuring device. <6yrs: not recommended. 6–11yrs: 2.5mL every 4–6hrs as needed; max 15mL/24hrs.
Risks from concomitant benzodiazepines or other CNS depressants (see Interactions). Risk of life-threatening respiratory depression (esp. in children). Abuse potential (monitor). Head injury, other intracranial lesions or pre-existing increase in intracranial pressure. Acute abdomen. Hypothyroidism. Addison's disease. Prostatic hypertrophy. Urethral stricture. Asthma. Narrow-angle glaucoma. Severe hepatic or renal impairment. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Increased risk of respiratory depression, sedation with benzodiazepines or other CNS depressants (eg, opioids, antihistamines, antipsychotics, anxiolytics, alcohol); avoid. May affect or be affected by MAOIs, TCAs.
Respiratory depression, drowsiness, hypertension, orthostatic hypotension, palpitations, anticholinergic effects, sedation, anxiety, nausea, rash, pruritus.
Formerly known under the brand name Hycodan.
Neurology Advisor Articles
- Combined Exercise Training Increases BDNF in Relapsing-Remitting MS
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Apheresis Associated With Clinical Improvement in Early Active Multiple Sclerosis
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Surgical Outcomes Associated With Trigger Site Deactivation for Migraines
- A Convenient Truth: The Problem With Seizure Under-Reporting and How to Fix It
- Incidence of Serotonin Syndrome With Co-Prescription of Triptans, Antidepressants
- Idiopathic Parkinson Disease May Increase Risk for Overactive Bladder
- Palliative Care in Movement Disorders: Recommendations for Improvement
- Cannabinoids May Be Effective as Adjunctive Treatment for Refractory Epilepsy